Pei‐Chi Kao

459 total citations
28 papers, 230 citations indexed

About

Pei‐Chi Kao is a scholar working on Neurology, Molecular Biology and Genetics. According to data from OpenAlex, Pei‐Chi Kao has authored 28 papers receiving a total of 230 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Neurology, 7 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Pei‐Chi Kao's work include Neuroblastoma Research and Treatments (9 papers), Glioma Diagnosis and Treatment (4 papers) and Renal Transplantation Outcomes and Treatments (3 papers). Pei‐Chi Kao is often cited by papers focused on Neuroblastoma Research and Treatments (9 papers), Glioma Diagnosis and Treatment (4 papers) and Renal Transplantation Outcomes and Treatments (3 papers). Pei‐Chi Kao collaborates with scholars based in United States, Canada and Taiwan. Pei‐Chi Kao's co-authors include Yen‐Hsuan Ni, Jia‐Feng Wu, Mei‐Hwei Chang, Clement Ma, Wendy B. London, Leslie Lehmann, Christine Duncan, Huey‐Ling Chen, Steven Margossian and Hong‐Yuan Hsu and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Hepatology.

In The Last Decade

Pei‐Chi Kao

23 papers receiving 228 citations

Peers

Countries citing papers authored by Pei‐Chi Kao

Since Specialization

Citations

This map shows the geographic impact of Pei‐Chi Kao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pei‐Chi Kao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pei‐Chi Kao more than expected).

Fields of papers citing papers by Pei‐Chi Kao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pei‐Chi Kao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pei‐Chi Kao. The network helps show where Pei‐Chi Kao may publish in the future.

Co-authorship network of co-authors of Pei‐Chi Kao

This figure shows the co-authorship network connecting the top 25 collaborators of Pei‐Chi Kao. A scholar is included among the top collaborators of Pei‐Chi Kao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pei‐Chi Kao. Pei‐Chi Kao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Improved Outcomes for Older Children, Adolescents, and Young Adults With Neuroblastoma in the Post‐Immunotherapy Era: An Updated Report From the International Neuroblastoma Risk Group	Pediatric Blood & Cancer	Rebecca Deyell, Pei‐Chi Kao et al.	0
2	A Phase 1 Trial of Fimepinostat in Children and Adolescents With Relapsed and Refractory Solid and CNS Tumors	Cancer Medicine	David S. Shulman, Kieuhoa T. Vo et al.	0
3	Statistical Fragility of Findings From Randomized Phase 3 Trials in Pediatric Oncology	Cancer Medicine	Pei‐Chi Kao, David S. Shulman et al.	0
4	Phase IB study of tovorafenib for children with relapsed/recurrent low-grade gliomas and other MAPK pathway activated tumors.	Journal of Clinical Oncology	Karen Wright, Cassie Kline et al.	1
5	Phase 2 trial of palbociclib and ganitumab in patients with relapsed Ewing sarcoma	Cancer Medicine	David S. Shulman, Priscilla Merriam et al.	21
6	Tolerability of ifosfamide‐containing regimen in patients with high‐risk renal and INI‐1‐deficient tumors	Pediatric Blood & Cancer	Daniel J. Benedetti, Pei‐Chi Kao et al.	3
7	Pediatric transplant–associated thrombotic microangiopathy health care utilization and implications of eculizumab therapy	Blood Advances	Michelle Long Schoettler, Leslie Lehmann et al.	1
8	Patient and Parent-Reported Outcomes Post-Treatment with Shmir-Based Lentiviral Gene Therapy for Sickle Cell Disease	Blood	Pei‐Chi Kao, Emma Morris et al.	1
9	Clinical and biological features prognostic of survival after relapse or progression of INRGSS stage MS pattern neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project	Pediatric Blood & Cancer	Kevin Campbell, Pei‐Chi Kao et al.	7
10	CTNI-53. PNOC014: PHASE IB STUDY RESULTS OF DAY101(TOVORAFENIB) FOR CHILDREN WITH LOW-GRADE GLIOMAS (LGGS) AND OTHER RAS/RAF/MEK/ERK PATHWAY-ACTIVATED TUMORS	Neuro-Oncology	Karen Wright, Cassie Kline et al.	9
11	Survival of patients with neuroblastoma before versus after reduction of therapy due to the change in age cut-off from 12 to 18 months in Children’s Oncology Group (COG) risk stratification.	Journal of Clinical Oncology	Wendy B. London, Hannah Bender et al.	0
12	Phase 2 trial of palbociclib and ganitumab in patients with relapsed Ewing sarcoma.	Journal of Clinical Oncology	David S. Shulman, Priscilla Merriam et al.	3
13	Hypothyroidism Is Correlated with Ventilator Complications and Longer Hospital Days after Coronary Artery Bypass Grafting Surgery in a Relatively Young Population: A Nationwide, Population-Based Study	Journal of Clinical Medicine	Pei‐Chi Kao, Yi‐Ting Tsai et al.	2
14	Symptoms and Suffering at End of Life for Children With Complex Chronic Conditions	Journal of Pain and Symptom Management	Pei‐Chi Kao, Clement Ma et al.	17
15	Phase II study of nivolumab and ipilimumab in children and young adults with INI1-negative cancers.	Journal of Clinical Oncology	Suzanne J. Forrest, Cassie Kline et al.	4
16	Clinical impact of molecular tumor profiling in pediatric, adolescent, and young adult patients with extra-cranial solid malignancies: An interim report from the GAIN/iCat2 study.	Journal of Clinical Oncology	Alanna J. Church, Laura Corson et al.	2
17	18420 A retrospective multicenter study of fatal pediatric melanoma	Journal of the American Academy of Dermatology	Elena B. Hawryluk, Pei‐Chi Kao et al.	1
18	A high serum interleukin‐12p40 level prior to Kasai surgery predict a favourable outcome in children with biliary atresia	Liver International	Jia‐Feng Wu, Pei‐Chi Kao et al.	16
19	Tumour necrosis factor-α promoter region polymorphisms affect the course of spontaneous HBsAg clearance	Liver International	Pei‐Chi Kao, Jia‐Feng Wu et al.	25
20	Involvement of Ca2+ signaling in tachykinin-mediated contractile responses in swine trachea	Journal of Biomedical Science	Yi-Ruu Lin, Pei‐Chi Kao et al.	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact